Tellgen Corporation (SHE:300642)

Market Cap	2.05B -7.9%
Revenue (ttm)	371.54M -11.2%
Net Income	-2.44M
EPS	-0.02
Shares Out	159.86M
PE Ratio	n/a
Forward PE	n/a
Dividend	0.10 (0.77%)
Ex-Dividend Date	May 26, 2026

Volume	2,198,477
Open	13.10
Previous Close	12.83
Day's Range	12.40 - 13.10
52-Week Range	12.40 - 32.80
Beta	0.30
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About Tellgen

Tellgen Corporation researches and develops, manufactures, and distributes IVDs in China and internationally. The company offers tumor markers; cervical cancer and HPV testing kits; Y chromosome microdeletions test kits; autoimmune; tumor methylation; cardiovascular, eugenics, and inflammation. It also provides diagnostic reagents/testing instruments and assembly lines. The company was founded in 2003 and is based in Shanghai, China.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2003
• Employees: 683
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300642

Financial Performance

In 2025, Tellgen's revenue was 363.83 million, a decrease of -16.70% compared to the previous year's 436.78 million. Earnings were 3.59 million, a decrease of -89.61%.